Loading clinical trials...
Loading clinical trials...
Evaluation of the Efficacy and Tolerability of Autologous Intralesional Platelet-rich Plasma, Topical Silymarin, and Combined Autologous Intralesional Platelet-rich Plasma With Topical Silymarin in the Treatment of Melasma
Conditions
Interventions
PRP
sylimarin cream
Locations
1
Egypt
Sohag University Hospital
Sohag, Egypt
Start Date
May 1, 2022
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2022
Last Updated
November 25, 2022
NCT06516419
NCT07296549
NCT06644157
NCT07345507
NCT06957834
NCT05326997
. Mohammed A ali, assistant professor
CONTACT
Lead Sponsor
Sohag University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions